Over the last 7 days, the Pharma industry has dropped 2.6%, driven by a pullback from Caliway Biopharmaceuticals of 14%. On the other hand Oneness Biotech is actually up 16%. This takes the industry's 12 month performance to a gain of 9.7%. Earnings are forecast to grow by 42% annually.
Has the Taiwanese Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Jul 2024 | NT$686.2b | NT$100.5b | NT$6.8b | 32.1x | 100.5x | 6.8x |
Sun, 23 Jun 2024 | NT$658.2b | NT$100.4b | NT$7.2b | 30.6x | 92x | 6.6x |
Tue, 21 May 2024 | NT$631.4b | NT$100.4b | NT$7.1b | 31.2x | 88.3x | 6.3x |
Thu, 18 Apr 2024 | NT$637.7b | NT$101.7b | NT$9.3b | 26.9x | 68.6x | 6.3x |
Sat, 16 Mar 2024 | NT$616.5b | NT$100.1b | NT$8.7b | 23.8x | 70.7x | 6.2x |
Mon, 12 Feb 2024 | NT$597.8b | NT$101.6b | NT$8.2b | 23.4x | 73.3x | 5.9x |
Wed, 10 Jan 2024 | NT$576.8b | NT$101.9b | NT$7.8b | 24x | 74x | 5.7x |
Fri, 08 Dec 2023 | NT$578.4b | NT$101.6b | NT$7.7b | 23.3x | 75.5x | 5.7x |
Sun, 05 Nov 2023 | NT$549.3b | NT$101.7b | NT$9.7b | 22x | 56.9x | 5.4x |
Tue, 03 Oct 2023 | NT$550.4b | NT$101.7b | NT$9.6b | 22.2x | 57.2x | 5.4x |
Thu, 31 Aug 2023 | NT$554.0b | NT$101.7b | NT$9.6b | 22.1x | 57.6x | 5.4x |
Sat, 29 Jul 2023 | NT$580.8b | NT$98.7b | NT$10.1b | 16.9x | 57.7x | 5.9x |
Mon, 26 Jun 2023 | NT$578.4b | NT$98.7b | NT$10.1b | 17.1x | 57.5x | 5.9x |
Wed, 24 May 2023 | NT$594.3b | NT$93.8b | NT$9.4b | 19.7x | 63.3x | 6.3x |
Fri, 21 Apr 2023 | NT$585.7b | NT$91.6b | NT$8.6b | 22.3x | 68.3x | 6.4x |
Sun, 19 Mar 2023 | NT$535.1b | NT$86.0b | NT$7.5b | 20x | 71.2x | 6.2x |
Tue, 14 Feb 2023 | NT$539.9b | NT$84.6b | NT$7.9b | 23.4x | 68.5x | 6.4x |
Thu, 12 Jan 2023 | NT$480.7b | NT$84.6b | NT$7.9b | 20.3x | 61x | 5.7x |
Sat, 10 Dec 2022 | NT$488.7b | NT$84.6b | NT$7.9b | 18.6x | 62x | 5.8x |
Mon, 07 Nov 2022 | NT$411.1b | NT$79.9b | NT$4.6b | 16.2x | 88.9x | 5.1x |
Wed, 05 Oct 2022 | NT$431.1b | NT$78.9b | NT$4.3b | 17.6x | 99.6x | 5.5x |
Fri, 02 Sep 2022 | NT$479.4b | NT$78.9b | NT$4.3b | 18.9x | 110.8x | 6.1x |
Sun, 31 Jul 2022 | NT$394.9b | NT$76.8b | NT$4.5b | 21.5x | 88.2x | 5.1x |
Tue, 28 Jun 2022 | NT$403.4b | NT$76.8b | NT$4.4b | 21.7x | 92.3x | 5.3x |
Thu, 26 May 2022 | NT$374.1b | NT$76.8b | NT$4.4b | 19.8x | 85.6x | 4.9x |
Sat, 23 Apr 2022 | NT$404.9b | NT$76.5b | NT$6.5b | 22.3x | 62.1x | 5.3x |
Mon, 21 Mar 2022 | NT$394.7b | NT$76.9b | NT$8.7b | 20.7x | 45.6x | 5.1x |
Wed, 16 Feb 2022 | NT$389.7b | NT$76.7b | NT$8.5b | 19x | 46x | 5.1x |
Fri, 14 Jan 2022 | NT$377.7b | NT$76.7b | NT$8.5b | 18.2x | 44.6x | 4.9x |
Sun, 12 Dec 2021 | NT$395.8b | NT$76.7b | NT$8.5b | 17.7x | 46.8x | 5.2x |
Tue, 09 Nov 2021 | NT$365.8b | NT$75.7b | NT$10.1b | 17.4x | 36.2x | 4.8x |
Thu, 07 Oct 2021 | NT$337.2b | NT$76.0b | NT$10.7b | 17.4x | 31.4x | 4.4x |
Sat, 04 Sep 2021 | NT$354.9b | NT$76.0b | NT$10.7b | 19.8x | 33.1x | 4.7x |
Mon, 02 Aug 2021 | NT$362.6b | NT$76.0b | NT$10.7b | 21.4x | 33.8x | 4.8x |
33.8x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | -2.30% | |
Healthcare | -2.09% | |
Pharma | -1.83% | |
Pharma | -1.83% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
4743 Oneness Biotech | NT$176.20 | 9.5% +NT$7.3b | -6.8% | PS929.8x | |
1720 Standard Chemical & Pharmaceutical | NT$78.30 | 6.5% +NT$857.7m | 21.8% | PE16x | |
3705 YungShin Global Holding | NT$54.00 | 4.0% +NT$559.4m | 23.1% | PE15.6x | |
1795 Lotus Pharmaceutical | NT$284.50 | 0.5% +NT$397.5m | -0.5% | PE19.1x | |
4114 Synmosa Biopharma | NT$40.50 | 2.0% +NT$305.6m | 2.6% | PE23.8x |